Recurrent Radiation Retinopathy and Optic Neuropathy after Cranial Irradiation Therapy Treated by Intravitreal Bevacizumab

2016 ◽  
Vol 6 (2) ◽  
pp. 1-5
Author(s):  
Serdar Ozates ◽  
Mert Simsek ◽  
Mehmet Citirik
Keyword(s):  
Optic Neuropathy ◽  
Intravitreal Bevacizumab ◽  
Cranial Irradiation ◽  
Radiation Retinopathy ◽  
Irradiation Therapy

Anterior ischemic optic neuropathy following intravitreal bevacizumab

2010 ◽  
Vol 54 (3) ◽  
pp. 252-254 ◽  
Author(s):  
Jane Y. Huang ◽  
Hiroaki Ozaki ◽  
Hideyuki Hayashi ◽  
Eiichi Uchio
Keyword(s):  
Optic Neuropathy ◽  
Intravitreal Bevacizumab ◽  
Anterior Ischemic Optic Neuropathy ◽  
Ischemic Optic Neuropathy

scholarly journals The Role of Combined Therapy in the Treatment of Retinopathy and Optic Neuropathy Due to Radiotherapy in the Uveal Melanoma

2020 ◽  
Vol 6 (01) ◽  
pp. 01-02
Author(s):  
Yasemin Benderli Cihan
Keyword(s):  
Uveal Melanoma ◽  
Optic Neuropathy ◽  
Combined Therapy ◽  
Tumor Resection ◽  
Transpupillary Thermotherapy ◽  
Particle Radiation ◽  
Radiation Retinopathy ◽  
Low Incidence ◽  
Plaque Brachytherapy

Abstract Introduction Uveal melanoma has a relatively low incidence. Transpupillary thermotherapy (TTT), hypofractioned stereotactic radiotherapy (RT), stereotactic radiosurgery, plaque brachytherapy, charged particle radiation therapy, local tumor resection, enucleation, and exantation are applied in the treatment. Methods The importance given to radiotherapy has increased to get more satisfactory results while treating the patient. However, it is the treatment of radiation retinopathy and optic neuropathy from complications. Results Radiation retinopathy and optic neuropathy are the most important complications related to radiotherapy in the treatment of uveal melanoma. In recent years, many studies have been performed on the treatment of radiation retinopathy and optic neuropathy. Conclusion The consecutive use of triamcinolone in combination with anti-VEGF supports that it may be a future therapeutic agent in the treatment of complications.

Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma

2016 ◽  
Vol 254 (9) ◽  
pp. 1787-1792 ◽  
Author(s):  
Ira Seibel ◽  
Dino Cordini ◽  
Annette Hager ◽  
Johanna Tillner ◽  
Aline I. Riechardt ◽  
...  
Keyword(s):  
Risk Factors ◽  
Proton Beam ◽  
Uveal Melanoma ◽  
Optic Neuropathy ◽  
Proton Beam Therapy ◽  
Radiation Retinopathy ◽  
Predictive Risk

scholarly journals Intravitreal bevacizumab (Avastin®) for radiation retinopathy neovascularization

2008 ◽  
Vol 86 (1) ◽  
pp. 115-116 ◽  
Author(s):  
Pedro Arriola-Villalobos ◽  
Juan Donate-López ◽  
Cristina Calvo-González ◽  
Juan Reche-Frutos ◽  
Nicolás Alejandre-Alba ◽  
...  
Keyword(s):  
Intravitreal Bevacizumab ◽  
Radiation Retinopathy
Sign in / Sign up

Export Citation Format

Share Document